Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janice L Hyatt

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Bioorganic & Medicinal Chemistry|July 8, 2011
Requirements for mammalian carboxylesterase inhibition by substituted ethane-1,2-dionesElizabeth I Parkinson, M Jason Hatfield, Lyudmila Tsurkan, et al.
Cancer Research|August 3, 2005
Brain tumor oncolysis with replication-conditional herpes simplex virus type 1 expressing the prodrug-activating genes, CYP2B1 and secreted human intestinal carboxylesterase, in combination with cyclophosphamide and irinotecanEdyta Tyminski, Stanley Leroy, Kinya Terada, et al.
Bioorganic & Medicinal Chemistry|April 3, 2007
Analysis of the inhibition of mammalian carboxylesterases by novel fluorobenzoins and fluorobenzilsLatorya D Hicks, Janice L Hyatt, Teri Moak, et al.
Journal of Medicinal Chemistry|November 26, 2010
Structure-activity relationships of substituted 1-pyridyl-2-phenyl-1,2-ethanediones: potent, selective carboxylesterase inhibitorsBrandon M Young, Janice L Hyatt, David C Bouck, et al.
Journal of Medicinal Chemistry|March 24, 2007
Selective inhibition of carboxylesterases by isatins, indole-2,3-dionesJanice L Hyatt, Teri Moak, M Jason Hatfield, et al.
Molecular Pharmacology|March 18, 2005
The crystal structure of the complex of the anticancer prodrug 7-ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxycamptothecin (CPT-11) with Torpedo californica acetylcholinesterase provides a molecular explanation for its cholinergic actionMichal Harel, Janice L Hyatt, Boris Brumshtein, et al.
Molecular Pharmacology|December 15, 2006
Analysis of mammalian carboxylesterase inhibition by trifluoromethylketone-containing compoundsRandy M Wadkins, Janice L Hyatt, Carol C Edwards, et al.
Cancer Chemotherapy and Pharmacology|May 27, 2005
Activation and antitumor activity of CPT-11 in plasma esterase-deficient miceChristopher L Morton, Lisa Iacono, Janice L Hyatt, et al.
Molecular Pharmacology|May 25, 2004
Discovery of novel selective inhibitors of human intestinal carboxylesterase for the amelioration of irinotecan-induced diarrhea: synthesis, quantitative structure-activity relationship analysis, and biological activityRandy M Wadkins, Janice L Hyatt, Kyoung Jin P Yoon, et al.
Chemico-Biological Interactions|November 1, 2005
Inhibition of acetylcholinesterase by the anticancer prodrug CPT-11Janice L Hyatt, Lyudmila Tsurkan, Christopher L Morton, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Bioorganic & Medicinal Chemistry|July 8, 2011
Requirements for mammalian carboxylesterase inhibition by substituted ethane-1,2-dionesElizabeth I Parkinson, M Jason Hatfield, Lyudmila Tsurkan, et al.
Cancer Research|August 3, 2005
Brain tumor oncolysis with replication-conditional herpes simplex virus type 1 expressing the prodrug-activating genes, CYP2B1 and secreted human intestinal carboxylesterase, in combination with cyclophosphamide and irinotecanEdyta Tyminski, Stanley Leroy, Kinya Terada, et al.
Bioorganic & Medicinal Chemistry|April 3, 2007
Analysis of the inhibition of mammalian carboxylesterases by novel fluorobenzoins and fluorobenzilsLatorya D Hicks, Janice L Hyatt, Teri Moak, et al.
Journal of Medicinal Chemistry|November 26, 2010
Structure-activity relationships of substituted 1-pyridyl-2-phenyl-1,2-ethanediones: potent, selective carboxylesterase inhibitorsBrandon M Young, Janice L Hyatt, David C Bouck, et al.
Journal of Medicinal Chemistry|March 24, 2007
Selective inhibition of carboxylesterases by isatins, indole-2,3-dionesJanice L Hyatt, Teri Moak, M Jason Hatfield, et al.
Molecular Pharmacology|March 18, 2005
The crystal structure of the complex of the anticancer prodrug 7-ethyl-10-[4-(1-piperidino)-1-piperidino]-carbonyloxycamptothecin (CPT-11) with Torpedo californica acetylcholinesterase provides a molecular explanation for its cholinergic actionMichal Harel, Janice L Hyatt, Boris Brumshtein, et al.
Molecular Pharmacology|December 15, 2006
Analysis of mammalian carboxylesterase inhibition by trifluoromethylketone-containing compoundsRandy M Wadkins, Janice L Hyatt, Carol C Edwards, et al.
Cancer Chemotherapy and Pharmacology|May 27, 2005
Activation and antitumor activity of CPT-11 in plasma esterase-deficient miceChristopher L Morton, Lisa Iacono, Janice L Hyatt, et al.
Molecular Pharmacology|May 25, 2004
Discovery of novel selective inhibitors of human intestinal carboxylesterase for the amelioration of irinotecan-induced diarrhea: synthesis, quantitative structure-activity relationship analysis, and biological activityRandy M Wadkins, Janice L Hyatt, Kyoung Jin P Yoon, et al.
Chemico-Biological Interactions|November 1, 2005
Inhibition of acetylcholinesterase by the anticancer prodrug CPT-11Janice L Hyatt, Lyudmila Tsurkan, Christopher L Morton, et al.
Pageof 3